Clinical Trial Update: Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral diindolylmethane (DIM) for the treatment of cervical dysplasia has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dysplasia

Drugs mentioned

• Diindolylmethane (diindolylmethane)

Snippet

Sponsor: New York Presbyterian Hospital | Conditions: Cervical Dysplasia | Phase 3 | Status: COMPLETED